NeuroOne Medical Technologies Corp. (NMTC)
0.95
-0.03
(-3.44%)
USD |
NASDAQ |
Oct 21, 09:56
NeuroOne Medical Technologies Enterprise Value : 6.690M for Oct. 20, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 20, 2026 | 6.690M |
| October 19, 2026 | 6.831M |
| October 16, 2026 | 6.495M |
| October 15, 2026 | 7.179M |
| October 14, 2026 | 7.353M |
| October 13, 2026 | 7.701M |
| October 12, 2026 | 7.483M |
| October 09, 2026 | 7.875M |
| October 08, 2026 | 7.527M |
| October 07, 2026 | 7.788M |
| October 06, 2026 | 7.962M |
| October 05, 2026 | 7.832M |
| October 02, 2026 | 7.875M |
| October 01, 2026 | 6.701M |
| September 30, 2026 | 7.092M |
| September 29, 2026 | 7.614M |
| September 28, 2026 | 9.442M |
| September 25, 2026 | 9.703M |
| September 24, 2026 | 9.703M |
| September 23, 2026 | 9.790M |
| September 22, 2026 | 10.14M |
| September 21, 2026 | 9.442M |
| September 18, 2026 | 10.22M |
| September 17, 2026 | 9.964M |
| September 16, 2026 | 10.40M |
| Date | Value |
|---|---|
| September 15, 2026 | 10.83M |
| September 14, 2026 | 11.18M |
| September 11, 2026 | 11.70M |
| September 10, 2026 | 11.88M |
| September 09, 2026 | 12.57M |
| September 08, 2026 | 12.84M |
| September 04, 2026 | 12.23M |
| September 03, 2026 | 12.57M |
| September 02, 2026 | 12.66M |
| September 01, 2026 | 12.14M |
| August 31, 2026 | 12.92M |
| August 28, 2026 | 13.53M |
| August 27, 2026 | 15.36M |
| August 26, 2026 | 15.53M |
| August 25, 2026 | 16.93M |
| August 24, 2026 | 16.75M |
| August 21, 2026 | 15.79M |
| August 20, 2026 | 16.84M |
| August 19, 2026 | 17.10M |
| August 18, 2026 | 14.49M |
| August 17, 2026 | 14.49M |
| August 14, 2026 | 15.01M |
| August 13, 2026 | 14.05M |
| August 12, 2026 | 11.36M |
| August 11, 2026 | 12.05M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 204.93B |
| AngioDynamics, Inc. | 477.80M |
| Alphatec Holdings, Inc. | 2.167B |
| AtriCure, Inc. | 2.840B |
| Baxter International, Inc. | 19.35B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.006M |
| Revenue (Quarterly) | 1.973M |
| Total Expenses (Quarterly) | 3.979M |
| EPS Diluted (Quarterly) | -0.2754 |
| Gross Profit Margin (Quarterly) | 59.94% |
| Profit Margin (Quarterly) | -101.7% |
| Earnings Yield | -97.03% |
| Normalized Earnings Yield | -99.56 |